Galderma Group AG (XSWX:GALD) Interest Expense: CHF-141 Mil (TTM As of Dec. 2025)


XSWX:GALD Galderma Group AG XSWX:GALD
15 GF Score
Price CHF183.90
! 4 Warning Signs
View Full Analysis

What is Galderma Group AG Interest Expense?

Galderma Group AG XSWX:GALD -1.02% 15 Interest Expense is CHF-141 Mil as of Dec. 2025. GuruFocus rates XSWX:GALD with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Galderma Group AG's interest expense for the six months ended in Dec. 2025 was CHF -63 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-141 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Galderma Group AG's Operating Income for the six months ended in Dec. 2025 was CHF 389 Mil. Galderma Group AG's Interest Expense for the six months ended in Dec. 2025 was CHF -63 Mil. Galderma Group AG's Interest Coverage for the quarter that ended in Dec. 2025 was 6.18. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Galderma Group AG  (XSWX:GALD) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Galderma Group AG's Interest Expense for the six months ended in Dec. 2025 was CHF-63 Mil. Its Operating Income for the six months ended in Dec. 2025 was CHF389 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was CHF2,143 Mil.

Galderma Group AG's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2025 )/Interest Expense (Q: Dec. 2025 )
=-1*388.887/-62.955
=6.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Galderma Group AG Interest Expense Historical Data

* Premium members only.

The historical data trend for Galderma Group AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galderma Group AG Interest Expense Chart

Galderma Group AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
-324.84 -371.15 -487.75 -317.41 -139.46

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Expense Get a 7-Day Free Trial -230.04 -210.94 -106.99 -78.07 -62.96
XSWX:GALD
15GF Score
Galderma Group AG XSWX:GALD
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galderma Group AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-141 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of CHF-141 Mil mean?
Galderma Group AG (XSWX:GALD) has a Interest Expense of CHF-141 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Galderma Group AG and its competitors.
Is Galderma Group AG's Interest Expense too high?
Galderma Group AG's current Interest Expense is CHF-141 Mil. Overall, Galderma Group AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's Interest Expense compare to ZTS and UTHR?
Galderma Group AG's Interest Expense of CHF-141 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Galderma Group AG and its competitors. Galderma Group AG's current Interest Expense is CHF-141 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current Interest Expense of CHF-141 Mil. The current Interest Expense is CHF-141 Mil. Galderma Group AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current Interest Expense is CHF-141 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galderma Group AG Business Description

Address Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
15GF Score

Get the complete analysis for XSWX:GALD

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF183.90
Price